Go Back to Match Results for "trials"

The CHEC-SC Cohort Study: CHaractErizing CFTR Modulated Changes in Sweat Chloride and their Association with Clinical Outcomes (the CHEC-SC study)
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
-
Conditions: cystic fibrosis
-
Age: Between 1 - 100 Years
-
Gender: Male or Female
Inclusion Criteria
Documentation of a CF diagnosis
Current treatment with a prescribed commercially approved CFTR modulator for at least 3 months prior to enrollment
Exclusion Criteria
Presence of a condition or abnormality that, in the opinion of the Investigator, would compromise the safety of the patient or the quality of the data
Currently enrolled in an investigational trial (including open-label follow-on studies and EAPs) of an agent expected to have an impact on sweat chloride
Recruitment Status
OpenContact the research team to learn more about this study.
Fields marked with asterisk (*) are required